chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site swelling, Nausea, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 26 year old female with no illness at the time of being vaccinated, asthma, and no history of drug reactions/allergies who on 17-JAN-2007 was vaccinated with first dose of Pneumovax 23 (lot # 654977/0888F) in the deltoid at 8:30 AM.  Concomitant therapy included influenza virus vaccine (unspecified) was also given on 17-JAN-2007.  Other concomitant therapy included birth control, ADVAIR, albuterol, and ZYRTEC.  On 18-JAN-2007, at 8 AM, the patient experienced fever, nausea, chills, dizziness, swelling, redness, and soreness at the injection site.  The patient sought medical attention.  The injection site had a softball size swelling with tenderness.  Treatment was supportive.  No diagnostic studies were performed.  At the time of reporting, the patient was recovering.  Additional information was received from the physician.  The patient was treated with non-steroidal anti-inflammatory drugs (NSAIDS), rest, and fluids.  On 20-JAN-2007, the patient recovered. No additional information is expected.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning an adult patient with no known drug allergies who on an unspecified date was vaccinated intramuscularly with a 0.5 mL dose of Pneumovax 23 (lot 655587/0882F). Within 24 hours of vaccination, the patient developed redness, pain, and swelling at injection site. The patient sought unspecified medical attention. No other symptoms were noted. Subsequently, the patient recovered from all symptoms. Additional information has been requested.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Initial and follow up information has been received from a healthcare worker and a health professional concerning a 76 year old female patient who on 19-OCT-2006 was vaccinated IM with her first dose of Pneumovax 23, lot #651399/0486F. Subsequently, the patient developed injection site erythema and injection site swelling. It was later reported that on 23-OCT-2006 the patient called the office and indicated she had redness of entire right arm after the injection. No medical attention was sought. The patient was advised never to get the injection again. Her outcome was not reported. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: PPV, TTOX
Symptoms: Immediate post-injection reaction, Incorrect dose administered, Injection site pain
Clinical narrative: Information has been received from a licensed practical nurse concerning a 65 year old female with hypertension, hyperlipidaemia, gastroesophagel reflux disease and sulfonamide allergy who on 23-JAN-2007 was vaccinated IM, in the right deltoid, with a 2 ml dose of Pneumovax 23 (lot #655152/0889F). Concomitant therapy included tetanus toxoid (in the opposite arm), potassium (unspecified), ACIPHEX, ADALAT CC, simvastatin (MSD), MAXZIDE and aspirin. The patient reported that there was discomfort at the time of the injection. The injection site was rubbed and massaged to help relieve the discomfort. On 23-JAN-2007, the patient recovered from the discomfort at the injection site. Additional information is not expected.
Age: 53.0
Sex: M
Vaccine: PPV
Symptoms: Fatigue, Lymphoedema, Malaise, Pain
Clinical narrative: Information has been received from a 53 year old male physician with hyperlipidaemia, hypothyroidism, allergic rhinitis, and drug allergies to penicillin, cephalosporins, and NSAIDs who in 2001 was vaccinated with a first dose of Pneumovax 23 vaccine. On 22-JAN-2007, the physician was vaccination with a second dose of Pneumovax 23 (lot 655501/1035F). There was no concomitant medication. On 23-JAN-2007 the physician developed lymphoedema in the injected arm, fatigue, pain and malaise. The physician sought unspecified medical attention. At the time of this report, the physician was recovering. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: PPV
Symptoms: Urticaria
Clinical narrative: Initial and follow up information has been received from a physician concerning a 12 year old male patient with allergic rhinitis and skin test positive to multiple molds who on 22-SEP-2006 was vaccinated with a first dose of Pneumovax 23.  One hour later, the patient developed hives.  He was treated with an antihistamine.  The physician indicated that there were no other symptoms and that the hives were self-limiting with no major treatment needed.  On the same day, the patient recovered.  Additional information is not expected.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Incorrect dose administered, Local reaction, Overdose, Pain
Clinical narrative: Information has been received from a registered nurse concerning a 69 year old female who was vaccinated with Pneumovax 23 1.0 ml dose instead of 0.5 ml dose.  Subsequently the patient experienced mild local reaction with redness and pain.  Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 64 year old female with high blood pressure and hypertension. On 22-JAN-2007, the patient was vaccinated intramuscularly in the left deltoid with 0.5 mL of Pneumovax 23. On 25-JAN-2007, the patient developed an injection site reaction. It was reported that the patient developed irregular patches of redness 19 by 15 cm. On 25-JAN-2007, the patient was given ROCEPHIN. The patient sought unspecified medical attention. At the time of this report, the outcome of the events were unknown. Additional information has been requested.  07/30/2008 This is in follow-up to report(s) previously submitted on 7/30/2007. Initial and follow up information has been received from a licensed visiting nurse, concerning a 64 year old female, with no known drug allergies, high blood pressure and hypertension. On 22-JAN-2007, at 5:03pm, the patient was vaccinated intramuscularly in the left deltoid with 0.5 mL dose of PNEUMOVAX (Lot #655589/1137F). There was no illness at the time of vaccination. On 23-JAN-2007 (previously reported as 25-JAN-2007), the patient developed an injection site reaction. It was originally reported that the patient developed irregular patches of redness 19 by 15 cm, but follow up information clarified the patient developed swelling, redness, warmth and pain over an area of 38cm, up and down the lateral upper arm, and past the distal arm to the elbow and into the forearm. On 25-Jan-2007, the patient was given ROCEPHIN. On 02-FEB-2007, the patient had recovered from the events. No further information is expected.
Sex: M
Vaccine: PPV
Symptoms: Feeling abnormal, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a wholesale representative and a nurse concerning a male who on an unspecified date was vaccinated with Pneumovax 23 (lot # 655290/0959F).  Subsequently the patient experienced pain, soreness to touch, redness, warmth, and swelling in the injection site arm.  The patient complained that it "hurt so bad he could not lie on it".  The patient also complained that he "felt lopsided".  Unspecified medical attention was sought.  At the time of this report, the outcome of the events was unknown.  Additional information has been requested.
Age: 60.0
Sex: U
Vaccine: PPV
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Information has been received from a nurse concerning a patient over the age of 60 years who on 08-JAN-2007, in the am, was vaccinated with Pneumovax 23 (lot # 655591/0886F). Subsequently, on an unspecified date, the patient's arm became red, hot and swollen from the shoulder to the elbow. Unspecified medical attention was sought. Subsequently , the patient recovered. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a nurse concerning a patient over the age of 60 years who on 11-JAN-2007 was vaccinated intramuscularly with Pneumovax 23 (lot # 655691/0886F).  Subsequently the patient developed redness and swelling at the injection site.  Unspecified medical attention was sought.  The patient subsequently recovered from the injection site redness and swelling.  Additional information has been requested.
Age: 60.0
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a patient over the age of 60 years, who on 11-JAN-2007 was vaccinated intramuscularly with Pneumovax 23 (lot # 655591/0886F). Subsequently, on an unspecified date, the patient developed injection site redness, swelling, and warmth. Unspecified medical attention was sought. The patient subsequently recovered from the injection site redness, swelling, and warmth. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a patient over the age of 60 years who on 25-JAN-2007 was vaccinated intramuscularly with Pneumovax 23 (lot # 655591/0886F).  Subsequently, on an unspecified date, the patient developed injection site redness, warmth, and swelling.  Unspecified medical attention was sought.  The patient subsequently recovered from the injection site redness, warmth, and swelling.  Additional information has been requested.
Age: 76.0
Sex: M
Vaccine: PPV
Symptoms: Allergy test, Injection site cellulitis, Injection site pain, Oedema peripheral, Pain in extremity
Clinical narrative: Information has been received from a licensed practical nurse concerning a 76 year old male with no medical history or known drug allergies who on 01-FEB-2007 was vaccinated at 12:30 intramuscularly into the left deltoid with a dose of Pneumovax (Lot # 655152/0889F). Concomitant therapy included PRILOSEC, ROZEREM and diltiazem hydrochloride. On 02-FEB-2007 at 14:00, the patient developed swelling and tenderness in the arm that was vaccinated. The patient also experienced pain at the injection site and pain of the upper part of the arm. the patient was told to place hot packs on his arm and was being treated with cephalexin. The patient was diagnosed with cellulitis at the injection site. it was noted that the patient had allergy testing two days prior to vaccination. At the time of this report, the patient had recovered. No product quality complaint was involved. Additional information is not expected.
Age: 76.0
Sex: M
Vaccine: PPV
Symptoms: Tenderness
Clinical narrative: Information has been received from a licensed practical nurse concerning a 76 year old male with no medical history or known drug allergies who on 01-FEB-2007 was vaccinated at 12:30 intramuscularly into the left deltoid with a dose of Pneumovax (Lot # 655152/0889F). Concomitant therapy included PRILOSEC, ROZEREM and diltiazem hydrochloride. On 02-FEB-2007 at 14:00, the patient developed swelling and tenderness in the arm that was vaccinated. The patient also experienced pain at the injection site and pain of the upper part of the arm. the patient was told to place hot packs on his arm and was being treated with cephalexin. The patient was diagnosed with cellulitis at the injection site. it was noted that the patient had allergy testing two days prior to vaccination. At the time of this report, the patient had recovered. No product quality complaint was involved. Additional information is not expected.
Age: 83.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis, Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered pharmacist concerning an 83 year old female with allergy to beta blockers and macrolides and a history of pneumonia who on 01-FEB-2007 was vaccinated with Pneumovax (0.5 ml), intramuscularly. Concomitant therapy included albuterol, COREG, CEFTIN, citalopram, ANZEMET, LASIX, ROBITUSSIN, SYNTHROID, nystatin, PROTONIX, SEROQUEL, COUMADIN and meclizine. On the morning of 02-FEB-2007 the patient developed an injection site reaction. The reaction was described as a cellulitis at the injection site and was swollen, red, and warm to touch. As of 02-FEB-2007 at 6:00 PM the reaction was "now traveling down the arm." Warm compresses were applied. At the time of the report the patient was considered to be not recovered. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Age: 51.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Nausea, Oedema peripheral, Pain, Pyrexia
Clinical narrative: information has been received from a certified medical assistant concerning a 51 year old male with high blood pressure, obesity and no known allergies or adverse drug reactions reported. On 25-JAN-2007, the patient was vaccinated intramuscularly in the right deltoid with 0.5 mL of Pneumovax (lot#654977/0888F). At the same time, the patient received influenza virus vaccine (unspecified) in the left arm. Concomitant therapy included LOTREL. The following day, the patient developed a high fever, aches and swollen right arm. It was reported that the patient was also "nauseated". The patient sought unspecified medical attention. The patient received an injection of DEPO-MEDROL and an order for MEDROL DOSEPAK. the symptoms had resolved. At the time of this report, the patient had recovered from the events (date unknown). Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female who in 2005 was vaccinated with Pneumovax. On an unspecified date, the patient developed cellulitis. the patient saw a dermatologist afterwards. At the time of this report, the outcome of the event was unknown. Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 75 year old female who on an unspecified date was vaccinated with Pneumovax 23 (lot # not reported).  Subsequently, the patient experienced injection site redness and swelling after receiving Pneumovax 23.  Medical attention was sought.  Subsequently, the patient recovered.  No other information was available at the time of reporting.  Additional information has been requested.
Age: 71.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature increased, Chills, Injection site nodule, Injection site swelling
Clinical narrative: Information has been received from a specialist and a Doctor of Pharmacy concerning a 71 year old male who on an unspecified date was vaccinated with a dose of Pneumovax 23 (lot 651437/0899F).  Subsequently, the patient experienced a "significant reaction" including "swelling, a large knot" at the injection site, elevated temperature and chills.  The patient was being treated with an unspecified antibiotic.  At the time of this report, the outcome was unknown.  The Pharm D. requested a lot check to be performed on lot 651437/ 0899F.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  The reporter felt that the patient's swelling at the injection site, increased body temperature, and chills were other important medical events.  Additional information has been requested.
Age: 1.5
Sex: U
Vaccine: PPV
Symptoms: No adverse reaction, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse concerning an 18 month old child (gender not reported) who in February 2007, "sometime this past week" was accidentally vaccinated with Pneumovax 23 (lot # not reported) 0.5 ml injection.  In February 2007, the patient was accidentally administered Pneumovax 23 instead of PREVNAR.  No adverse experience occurred in the patient.  No additional information was available at the time of reporting.  Additional information was received from the licensed practical nurse via telephone call.  The nurse reported that two different people were helping with the vaccinations.  The vaccines were close together and the person picked up the wrong vaccine.  To prevent a recurrence, a two check system has been put in place.  No additional information is expected.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Heat therapy, Injection site erythema, Injection site pain, Pain in extremity
Clinical narrative: Information has been received from a registered nurse concerning a 53-year-old white female pharmacy tech with allergies to codeine, NOVACAINE, had reactions to first few flu shots (had skin test), some environmental allergies and a history of asthma and hypertension who on 06-FEB-2007 was vaccinated with a dose of Pneumovax 23 (lot number 651406/0620F) IM at 2:15 PM. On 07-FEB-2007, the patient awoke during the first night after being vaccinated, with pain in her left arm. On 08-FEB-2007, she was seen in the physician's office. She had erythema at the injection site and tenderness in the left axilla (no enlarged lymph nodes were felt). The patient was being treated with warm compresses and ADVIL. Follow-up information was received from the registered nurse. At the time of reporting, the patient had recovered. No additional information is expected.
Age: 87.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Burning sensation
Clinical narrative: Information has been received from an 87 year old female with allergy to sulfa drugs and a history of gall bladder removal, who on 19-OCT-2006 was vaccinated by injection with a single dose of Pneumovax 23.  The patient concomitantly was vaccinated with influenza virus vaccine (unspecified), (name and manufacturer unknown) and other concomitant therapy included LASIX, DIOVAN and PROTONIX.  On the same day, 19-OCT-2006, the patient began to experience "severe burning feelings inside her entire body."  The patient reported that this only occurred at night and it had occurred every single night since this began.  She said that the outside of her body is cool even though she was "burning up inside."  She said that she was convinced that this was due to the Pneumovax 23, because in the past years she had received the same flu vaccine and had never had any adverse reactions from it.  The patient sought unspecified medical attention.  She added that she had gone for many different types of tests, but her physicians could not find anything to explain what she was experiencing.  Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injected limb mobility decreased, Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning his 18 year old daughter with asthma and no known drug allergies, who on 05-FEB-2007 was vaccinated with a dose of Pneumovax 23 (lot# 651539/0607R).  Concomitant therapy included montelukast sodium (MSD).  On 06-FEB-2007 the patient experienced fever, chills, and a rash from the shoulder to the elbow.  The consumer reported that his daughter received antibiotics and pain killers because she could not lift her arm.  No diagnostic laboratory studies were performed.  At the time of this report, she had not recovered.  No product quality complaint was involved.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered pharmacist concerning an adult patient (age and gender unknown) who was "recently" vaccinated intramuscularly with a 0.5 mL dose of Pneumovax 23.  Subsequently the patient developed injection site redness, swelling and local heat.  The patient sought unspecified medical attention.  At the time of this report, the patient was recovering.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered pharmacist concerning an adult patient (age and gender unknown) who was "recently vaccinated intramuscularly with a 0.5 mL dose of Pneumovax 23. Subsequently the patient developed injection site redness, swelling and local heat. The patient sought unspecified medical attention. At the time of this report, the patient was recovering. Additional information has been requested.
Sex: M
Vaccine: PPV, VARCEL
Symptoms: Erythema, Full blood count normal, Oedema peripheral, Pain in extremity
Clinical narrative: Information has been received from a physician concerning a male in his "early 60s" who, on 05-JAN-2007 at 12:30PM, was vaccinated into the right arm with a dose of Pneumovax 23 (Lot# 651318/1006P).  Concomitant suspect vaccination on the same day at 12:40PM included a first dose of Varivax (Oka/Merck) (MSD), administered into the left arm.  Shortly after vaccination, at 5:00PM, the patient's arm (unspecified) became swollen, red and painful.  The physician instructed the patient to go to the emergency room.  It was also noted that the patient was not admitted to the hospital.  The patient may have had bronchitis at the time of vaccination.  The physician reported in follow up that the patient was treated with BENADRYL and TYLENOL.  The symptoms were reported to have lasted 4-5 days.  The physician reported that the patient recovered 5 days later (09-JAN-2007).  Additional information is not expected.
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Bone pain, Electrocardiogram, Fatigue, Insomnia, Malaise
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old male with coronary artery disease, hyperthyroidism, colon polyps, benign prostatic hyperplasia and electrocardiogram abnormal on 08-DEC-2006, who was vaccinated SQ in the right arm with a 0.5 mL dose of Pneumovax 23 (Lot# 654981/0674F).  Concomitant therapy included NAPROSYN, aspirin, multivitamins and SYNTHROID.  The patient reported to the nurse on 14-FEB-2007, that on 08-DEC-2006, his reaction "felt like a near death experience".  Two months after his reaction, the patient reported that on 08-DEC-2006, he experienced severe pain in the right arm (injection site arm) that began at 4 pm.  At 6:30 PM on 08-DEC-2006, he "felt every bone in the body ached".  He pain was reported "10 out of 10" and "pain prevented him from sleeping until midnight".  On arising the morning of 09-DEC-2006, the patient still had severe pain in the right arm that was a "4 out of 10".  His tricep area hurt (approximately 09-DEC-2006).  The patient also mentioned that he had nasal congestion and sneezing that persisted, originally starting on 08-DEC-2006.  On 10-DEC-2006, he was extremely tired and had severe congestion.  His nasal congestion subsided but was still reported a nuisance.  The right arm pain was 4 out of 10 when flexed.  There was no account of the patient's experiences on 11-DEC-2006.  On 12-DEC-2006, when the patient flexed the right arm, there was no pain.  The patient pressed on the injection site and there was no pain and the patient felt his condition was good to normal.  The nurse felt that "the patient may have had a reaction because of a viral infection and the patient had localized pain to the right arm due to normal injection site reactions that are known for (Pneumovax 23)."  The patient felt that his reactions were life threatening however the nurse reported that they did not feel the event was serious in nature since the patient did not report his experiences until two months later and he did not seek medical care.  The patient had also reported that he did not go to the emergency room for his experiences.  The nurse also noted in the patient's chart in the allergy section, that no further shots should be given due to his reported experiences.  She clarified that they do not feel the patient had an allergic reaction but this was where she noted the information for future health providers.  Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Nasal congestion, Pain, Pain in extremity, Sneezing
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old male with coronary artery disease, hyperthyroidism, colon polyps, benign prostatic hyperplasia and electrocardiogram abnormal on 08-DEC-2006, who was vaccinated SQ in the right arm with a 0.5 mL dose of Pneumovax 23 (Lot# 654981/0674F).  Concomitant therapy included NAPROSYN, aspirin, multivitamins and SYNTHROID.  The patient reported to the nurse on 14-FEB-2007, that on 08-DEC-2006, his reaction "felt like a near death experience".  Two months after his reaction, the patient reported that on 08-DEC-2006, he experienced severe pain in the right arm (injection site arm) that began at 4 pm.  At 6:30 PM on 08-DEC-2006, he "felt every bone in the body ached".  He pain was reported "10 out of 10" and "pain prevented him from sleeping until midnight".  On arising the morning of 09-DEC-2006, the patient still had severe pain in the right arm that was a "4 out of 10".  His tricep area hurt (approximately 09-DEC-2006).  The patient also mentioned that he had nasal congestion and sneezing that persisted, originally starting on 08-DEC-2006.  On 10-DEC-2006, he was extremely tired and had severe congestion.  His nasal congestion subsided but was still reported a nuisance.  The right arm pain was 4 out of 10 when flexed.  There was no account of the patient's experiences on 11-DEC-2006.  On 12-DEC-2006, when the patient flexed the right arm, there was no pain.  The patient pressed on the injection site and there was no pain and the patient felt his condition was good to normal.  The nurse felt that "the patient may have had a reaction because of a viral infection and the patient had localized pain to the right arm due to normal injection site reactions that are known for (Pneumovax 23)."  The patient felt that his reactions were life threatening however the nurse reported that they did not feel the event was serious in nature since the patient did not report his experiences until two months later and he did not seek medical care.  The patient had also reported that he did not go to the emergency room for his experiences.  The nurse also noted in the patient's chart in the allergy section, that no further shots should be given due to his reported experiences.  She clarified that they do not feel the patient had an allergic reaction but this was where she noted the information for future health providers.  Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Information has been received from an office manager concerning a female who on 09-NOV-2006 was vaccinated with a dose of Pneumovax 23.  Subsequently the patient developed redness and a swollen arm.  At the time of the report, the patient's outcome was unknown.  Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Information has been received from an office manager concerning a female who on 09-NOV-2006 was vaccinated with a dose of Pneumovax 23.  Subsequently the patient developed redness and a swollen arm.  The patient's outcome was unknown.  Additional information has been requested.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Information has been received from an office manager concerning a female who on 09-NOV-2006 was vaccinated with a dose of Pneumovax 23.  Subsequently the patient developed redness and a swollen arm.  The patient's outcome was unknown.  Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a physician via a pharmacist and a health professional at a physician's office concerning a 77 year old male with diabetes, hypertension, hypercholesterolaemia and arteriosclerotic heart disease and a history of coronary artery bypass who on an unspecified date was vaccinated intramuscularly with Pneumovax 23 (lot # 654977/0888F).  Subsequently the patient developed cellulitis at the injection site.  Unspecified medical attention was sought.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Age: 79.0
Sex: F
Vaccine: PPV
Symptoms: Condition aggravated, Erythema, Hypersensitivity
Clinical narrative: Information has been received from a registered nurse concerning an 80 year old female with a history of tetanus.  On 17-OCT-2006, the patient was vaccinated intramuscularly in the right deltoid with the second dose of Pneumovax 23 (Lot# 651399/0486F).  At the time of the vaccination, the patient was noted to have redness of arm.  On 19-OCT-2006, the patient was seen in the emergency room (ER) with right forearm redness which he felt to be an allergic reaction to Pneumovax 23.  The patient was treated with steroid dosing and CEFALEXIN.  On 20-OCT-2006, the patient was seen in an office visit and her arm was feeling better with a little more redness.  It was reported that the patient was recommended not to receive the Pneumovax 23 again.  It was reported that the symptoms resolved.  At the time of this report, the patient had recovered from the events (date unknown).  It was reported that on 23-NOV-1999, the patient was vaccinated with the first dose of Pneumovax 23.  Additional information has been requested.
Age: 59.0
Sex: F
Vaccine: PPV
Symptoms: Muscular weakness, Pain
Clinical narrative: Information has been received from a company (SR# 142189577) concerning a 59 year old female who, on an unspecified date, was vaccinated with a dose of Pneumovax 23.  Concomitant therapy included REBIF.  Subsequently the patient "experienced achy symptoms and legs feel weak."  No further information is available.
Age: 60.0
Sex: M
Vaccine: PPV
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Information has been received from a nurse concerning a 60 year old male patient with an allergy to MACRODANTIN who on 26-FEB-2007 was vaccinated IM with a dose of Pneumovax 23, lot #655152/0889F.  Concomitant therapy included VICODIN, aspirin, atenolol, AVANDIA, glipizide, LIPITOR, lisinopril, MIRAPEX, vitamins (unspecified), carbidopa/levodopa (MSD), and VIAGRA.  On the evening of 26-FEB-2007 the patient experienced extreme pain in the right upper arm.  There was no redness or swelling.  The patient could not lift his arm.  Medical attention was sought.  At the time of the report the patient's symptoms persisted.  Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Incorrect dose administered, Incorrect route of drug administration, Injection site swelling, Injection site warmth, Oedema peripheral
Clinical narrative: Information has been received from a registered nurse concerning a 43 year old female who on 27-FEB-2007 was administered Pneumovax 23, 0.1 ml intradermally.  There was no concomitant medication.  On 27-FEB-2007, within several hours of the injection, the patient experienced pain, local heat at the injection site, and swelling from her elbow to her wrist.  Medical attention was sought.  The patient was treated with over-the-counter (OTC) BENADRYL and ice.  At the time of reporting, the patient was recovering.  No other information was available at the time of reporting.  Additional information has been requested. Additional information was received from the registered nurse. The patient experienced sweling at the site and forearm (minimal) which resolved completely in about 24 hours. The patient recovered in approximately 24 hours. No additional information is expected.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Pain
Clinical narrative: Information has been received from a registered nurse concerning a 43 year old female who on 27-FEB-2007 was administered Pneumovax 23, 0.1 ml intradermally.  There was no concomitant medication.  On 27-FEB-2007, within several hours of the injection, the patient experienced pain, local heat at the injection site, and swelling from her elbow to her wrist.  Medical attention was sought.  The patient was treated with over-the-counter (OTC) BENADRYL and ice.  At the time of reporting, the patient was recovering.  No other information was available at the time of reporting.  Additional information has been requested. Additional information was received from the registered nurse. The patient experienced sweling at the site and forearm (minimal) which resolved completely in about 24 hours. The patient recovered in approximately 24 hours. No additional information is expected.
Age: 75.0
Sex: M
Vaccine: PPV
Symptoms: Cough, Malaise
Clinical narrative: Information has been received from a registered nurse concerning a 75 year old male with diabetes, atrial fibrillation, glaucoma, hypertension and codeine allergy who approximately in November 2006 was vaccinated with Pneumovax 23.  On 27-FEB-2007, the patient was vaccinated, intramuscularly with a 0.5 mL dose of Pneumovax 23, (Lot # 651399/0486F).  Concomitant therapy included COUMADIN, ACTOS, DIOVAN, CARDIZEM, AMARYL, NEURONTIN and PROSCAR.  It was reported that within 24 hours, approximately on 28-FEB-2007, the patient reported that he wasn't "feeling good" and had a cough.  The patient sought unspecified medical attention.  At the time of the report, the patient had not recovered.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/30/2007. In follow-up it was reported by a health care professional concerning a 75 year old, male, whose reported weight was 230 pounds and whose reported height was 72 inches with diabetes, atrial fibrillation, glaucoma, hypertension and codeine allergy who approximately in November 2006 was vaccinated with PNEUMOVAX vaccine. On 27-FEB-2007, at 10:00 a.m., the patient was vaccinated intramuscularly into the right deltoid muscle with a 0.5 mL dose of PNEUMOVAX vaccine (Lot # 651399/0486F). It was reported that the patient stated that on 05-MAR-2007, he had a heaviness in his chest, no shortness of breath, but described a slight head cold (possibly unrealted). It was reported that the patient did not have any related serious event. The patient went to the physician and reportedly recovered on 15-MAR-2007. It was reported that the patinent's physician informed him that nothing would be done unless the patient had a significant change in health status. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site reaction, Local reaction
Clinical narrative: Information has been received from a county health registered nurse concerning a patient (age and gender not reported) who in 2006 was vaccinated intramuscularly with Pneumovax 23.  Subsequently, the patient developed a local site reaction post vaccination. The patient sought unspecified medical attention.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site reaction, Local reaction
Clinical narrative: Information has been received from a county health registered nurse concerning a patient (age and gender not reported) who in 2007 was vaccinated intramuscularly with Pneumovax 23.  Subsequently, the patient developed a local site reaction post vaccination. The patient sought unspecified medical attention.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Age: 59.0
Sex: M
Vaccine: PPV
Symptoms: Pain, Rash erythematous
Clinical narrative: Information has been received from a medical assistant concerning a 59 year old male who on 31-JAN-2007 was vaccinated with Pneumovax 23.  On 31-JAN-2007 the patient developed a dark red, painful rash down to the elbow of the inside of his arm (unspecified arm) following vaccination.  The rash did not itch.  The patient was told to take BENADRYL and the symptoms resolved in approximately 6 days.  Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: PPV, TTOX, VARZOS
Symptoms: Body temperature increased, Cardiac disorder, Drug hypersensitivity, Erythema, Gastrooesophageal reflux disease
Clinical narrative: Information has been received from a certified medical assistant concerning a 78 year old female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfonamide allergy who in 1995 was vaccinated with her first dose of Pneumovax 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left arm with the second dose of Pneumovax 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included Zostavax (Oka/Merck) (MSD) subcutaneously in the left arm and tetanus toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, atenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F, nausea, left arm pain, redness and swelling.  Treatment included an injection of an unspecified antibiotic.  At the time of this report, the outcome of the events was unknown.  Additional information has been requested.  This is in follow-up to report(s) previously submitted on 7/30/2007.  Initial and follow-up information has been received from a certified medical assistant concerning a 78 year old retired female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfanamide allergy who in 1995 was vaccinated with the first dose of PNEUMOVAX 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left deltoid with the second dose of PNEUMOVAX 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included ZOSTAVAX (Oka/Merck) subcutaneously in the left arm and Tetanus Toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, stenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F., nausea, left arm pain, redness and swelling.  It was also reported that the area was warm to touch.  Treatment included Reflex 500 mg twice daily times ten days.  At the time of this report, the outcome of the events was unknown.  No further information is expected.
Age: 78.0
Sex: F
Vaccine: PPV, TTOX, VARZOS
Symptoms: Hypertension, Nausea, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Information has been received from a certified medical assistant concerning a 78 year old female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfonamide allergy who in 1995 was vaccinated with her first dose of Pneumovax 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left arm with the second dose of Pneumovax 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included Zostavax (Oka/Merck) (MSD) subcutaneously in the left arm and tetanus toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, atenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F, nausea, left arm pain, redness and swelling.  Treatment included an injection of an unspecified antibiotic.  At the time of this report, the outcome of the events was unknown.  Additional information has been requested.  This is in follow-up to report(s) previously submitted on 7/30/2007.  Initial and follow-up information has been received from a certified medical assistant concerning a 78 year old retired female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfanamide allergy who in 1995 was vaccinated with the first dose of PNEUMOVAX 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left deltoid with the second dose of PNEUMOVAX 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included ZOSTAVAX (Oka/Merck) subcutaneously in the left arm and Tetanus Toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, stenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F., nausea, left arm pain, redness and swelling.  It was also reported that the area was warm to touch.  Treatment included Reflex 500 mg twice daily times ten days.  At the time of this report, the outcome of the events was unknown.  No further information is expected.
Age: 78.0
Sex: F
Vaccine: PPV, TTOX, VARZOS
Symptoms: Skin warm
Clinical narrative: Information has been received from a certified medical assistant concerning a 78 year old female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfonamide allergy who in 1995 was vaccinated with her first dose of Pneumovax 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left arm with the second dose of Pneumovax 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included Zostavax (Oka/Merck) (MSD) subcutaneously in the left arm and tetanus toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, atenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F, nausea, left arm pain, redness and swelling.  Treatment included an injection of an unspecified antibiotic.  At the time of this report, the outcome of the events was unknown.  Additional information has been requested.  This is in follow-up to report(s) previously submitted on 7/30/2007.  Initial and follow-up information has been received from a certified medical assistant concerning a 78 year old retired female with hypertension, gastrooesophageal reflux disease, cardiac disorder, penicillin allergy and sulfanamide allergy who in 1995 was vaccinated with the first dose of PNEUMOVAX 23.  On 27-FEB-2007, the patient was vaccinated intramuscularly in the left deltoid with the second dose of PNEUMOVAX 23 (0.5 ml) (lot # 655499/0988F).  Other vaccinations given on 27-FEB-2007 included ZOSTAVAX (Oka/Merck) subcutaneously in the left arm and Tetanus Toxoid intramuscularly in the right deltoid.  Other concomitant therapy included WAL-DRYL ALLERGY RELIEF, PRILOSEC, estradiol, stenolol, folic acid, aspirin and ascorbic acid.  The patient called her physician and then presented to the office on 01-MAR-2007 to report having experienced a fever of 100 F., nausea, left arm pain, redness and swelling.  It was also reported that the area was warm to touch.  Treatment included Reflex 500 mg twice daily times ten days.  At the time of this report, the outcome of the events was unknown.  No further information is expected.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Activities of daily living impaired, Arthralgia, Drug hypersensitivity, Eczema, Injection site pain
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with osteopenia and penicillin allergy and a history of chronic right leg injury due to motor vehicle accident, splenectomy and calculus renal who on 28-NOV-2006 was vaccinated intramuscularly in the left deltoid with the second dose of Pneumovax 23 (0.5 ml) (Lot # 655499/0988F). Concomitant therapy included ACTONEL, MAXAIR and calcium (unspecified). On 28-NOV-2006 the patient experienced pain at the injection site of the left deltoid which began a few hours after vaccination. Examination by the patient's physician on 29-NOV-2006 revealed a left deltoid muscle tenderness to palpation. Ice compresses and ADVIL was prescribed. The patient returned on 13-DEC-2006 complaining of continued pain. The physician recommended physical therapy which at the time of this report was ongoing. The patient's symptoms have improved but were not resolved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/30/2007. Initial and follow-up information has been received from a registered nurse and physical therapy notes concerning a 67 year old female with osteopenia and penicillin allergy and a history of chronic right leg injury due to motor vehicle accident, splenectomy and calculus renal who on 28-NOV-2006 at noon, was vaccinated intramuscularly in the left deltoid with the third dose of PNEUMOVAX vaccine (0.5 mL) (Lot # 655499/0988F). The patient had eczema at the time of vaccination. Concomitant therapy included ACTONEL, MAXAIR and calcium (unspecified). On 28-NOV-2006, at 4:00 PM, the patient experienced pain with any movement of the left arm which began several hours after vaccination. Examination by the patient's physician on 29-NOV-2006 revealed a left deltoid muscle tenderness to palpation. Ice compresses and ADVIL was prescribed. The patient returned on 13-DEC-2006 complaining of continued pain. The physician recommended physical therapy. Upon assessment from physical therapy, the patient complained of pain with functional range of motion less that 1/10. Diagnosis at the time included muscle spasms and joint pain. Physical therapy included ultrasound, moist heat, ice/cold pack, PROM. AROM, AAROM, strengthening, electric stim, joint mobilization, TENS, HEP, message and home exercise instructions. On 19-JAN-2007 the patient reporting that she was able to hold her hair drier better but continued to have problems reaching overhead especially dressing/grooming, and push/pull tasks. The patient also complained of being unable to get up from the floor and having sleeping difficulty. With difficulty getting comfortable and awakening 2 to 3 times per night. On 16-MAR-2007, the patient was discontinued from physical therapy after having slowly made gains, however continued to have pain with range of motion and ADL's. No further information is expected.